A proteomic approach revealed that in vivo PCB126 exposure regulated the expression of some proteins (HSP90 and Alpha-ETF) to compensate for the insulin resistance and protect against oxidative stress, while others (GRP78, NDKA/B and ribonuclease inhibitor) may represent an early sign of β-cell failure. The gene discussed is ETFA; the disease is Insulin resistance.